← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2008Last known activity
Nov 1, 2016
Acquired by Athenex, Inc. on May 5, 2021
Timeline
2000s
- Jun 1, 2005
Kuur Therapeutics— Founded
2010s
- Jul 12, 2016
Delenex Therapeutics AG— Acquired
- Jun 20, 2017
Catapult Therapy TCR— Acquired
2020s
- May 5, 2021
Athenex, Inc.— Acquired By
Drugs by trial phase (4 distinct, 8 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 1 via acquisition)
Indications
Subsidiaries (2 direct, 2 total across the full acquisition tree)
Recent trials (7)
- NCT02763254Study directorPhase 2Nov 1, 2016
- NCT02763254Lead sponsorPhase 2Nov 1, 2016
- NCT01948180Study directorPhase 2Sep 1, 2014
- NCT01948180Lead sponsorPhase 2Sep 1, 2014
- NCT01822093Lead sponsorPhase 1/Phase 2Dec 1, 2012
- NCT01220895Lead sponsorPhase 2Oct 1, 2010
- NCT01077908Lead sponsorPhase 3Jul 1, 2008
Details
- Founded
- London, GB Jun 1, 2005
- Last known activity
- Nov 1, 2016
Notes
Formerly Cell Medica